NFE2L3
Nuclear factor erythroid 2-related factor 3
Also known as: NF2L3_HUMAN, Nrf3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y4A8
- Gene
- NFE2L3
- Ensembl
- ENSG00000050344
- Chromosome
- 7
- Canonical length
- 694 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Vesicles
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene encodes a member of the cap 'n' collar basic-region leucine zipper family of transcription factors. The encoded protein heterodimerizes with small musculoaponeurotic fibrosarcoma factors to bind antioxidant response elements in target genes. This protein is a membrane bound glycoprotein that is targeted to the endoplasmic reticulum and the nuclear envelope. Pseudogenes of this gene are found on chromosomes 16, 17, and 18. [provided by RefSeq, Mar 2009]
Canonical amino-acid sequenceUniProt
694 residues, UniProt reviewed canonical sequence.
>Q9Y4A8|NFE2L3
1 MKHLKRWWSA GGGLLHLTLL LSLAGLRVDL DLYLLLPPPT LLQDELLFLG GPASSAYALS
61 PFSASGGWGR AGHLHPKGRE LDPAAPPEGQ LLREVRALGV PFVPRTSVDA WLVHSVAAGS
121 ADEAHGLLGA AAASSTGGAG ASVDGGSQAV QGGGGDPRAA RSGPLDAGEE EKAPAEPTAQ
181 VPDAGGCASE ENGVLREKHE AVDHSSQHEE NEERVSAQKE NSLQQNDDDE NKIAEKPDWE
241 AEKTTESRNE RHLNGTDTSF SLEDLFQLLS SQPENSLEGI SLGDIPLPGS ISDGMNSSAH
301 YHVNFSQAIS QDVNLHEAIL LCPNNTFRRD PTARTSQSQE PFLQLNSHTT NPEQTLPGTN
361 LTGFLSPVDN HMRNLTSQDL LYDLDINIFD EINLMSLATE DNFDPIDVSQ LFDEPDSDSG
421 LSLDSSHNNT SVIKSNSSHS VCDEGAIGYC TDHESSSHHD LEGAVGGYYP EPSKLCHLDQ
481 SDSDFHGDLT FQHVFHNHTY HLQPTAPEST SEPFPWPGKS QKIRSRYLED TDRNLSRDEQ
541 RAKALHIPFS VDEIVGMPVD SFNSMLSRYY LTDLQVSLIR DIRRRGKNKV AAQNCRKRKL
601 DIILNLEDDV CNLQAKKETL KREQAQCNKA INIMKQKLHD LYHDIFSRLR DDQGRPVNPN
661 HYALQCTHDG SILIVPKELV ASGHKKETQK GKRKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NFE2L3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.63
- Highest tissue expression
- 32 nTPM
Expression across tissuesHPA
Tissue
- placenta: 32 nTPM
- appendix: 10 nTPM
- duodenum: 7.5 nTPM
- lymph node: 7.5 nTPM
- spleen: 7.2 nTPM
- skin: 6.9 nTPM
Single-cell type
- epicardial cells: 1,051 nCPM
- syncytiotrophoblasts: 941 nCPM
- cytotrophoblasts: 471 nCPM
- paneth cells: 294 nCPM
- breast secretory cells: 236 nCPM
- migrating cytotrophoblasts: 216 nCPM
Immune cell
- myeloid DC: 0.6 nTPM
- T-reg: 0.6 nTPM
- memory CD4 T-cell: 0.4 nTPM
- MAIT T-cell: 0.3 nTPM
- classical monocyte: 0.2 nTPM
- intermediate monocyte: 0.2 nTPM
Brain region
- cerebellum: 59 nTPM
- cerebral cortex: 59 nTPM
- white matter: 39 nTPM
- pons: 33 nTPM
- basal ganglia: 32 nTPM
- medulla oblongata: 32 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.31
- gnomAD pLI
- 0
- gnomAD missense Z
- -3.75
- DepMap mean gene effect
- -0.33
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- integrated stress response signaling
- regulation of transcription by RNA polymerase II
- transcription by RNA polymerase II
Molecular functions
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NFE2L3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NFE2L3 as an antibody target. Whether an autoantibody or antibody against NFE2L3 could matter depends on whether native NFE2L3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NFE2L3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NFE2L3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...